These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10483921)

  • 1. Effect of a glutamate receptor antagonist (GYKI 52466) on 4-aminopyridine-induced seizure activity developed in rat cortical slices.
    Dóczi J; Banczerowski-Pelyhe I; Barna B; Világi I
    Brain Res Bull; 1999 Aug; 49(6):435-40. PubMed ID: 10483921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of spontaneous and evoked epileptiform activity in three in vitro epilepsy models.
    Gulyás-Kovács A; Dóczi J; Tarnawa I; Détári L; Banczerowski-Pelyhe I; Világi I
    Brain Res; 2002 Aug; 945(2):174-80. PubMed ID: 12126879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anticonvulsive effect of non-NMDA antagonist GYKI 52466 on 3-aminopyridine-induced primary and secondary cortical ictal activity in rat.
    Barna B; Szente M; Szász A
    Acta Biol Hung; 1999; 50(1-3):257-67. PubMed ID: 10574445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticonvulsive effect of AMPA receptor antagonist GYKI 52466 on 4-aminopyridine-induced cortical ictal activity in rat.
    Barna B; Szász A; Világi I; Szente M
    Brain Res Bull; 2000 Feb; 51(3):241-8. PubMed ID: 10718516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
    Löscher W; Hönack D
    Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMPA receptor antagonists, GYKI 52466 and NBQX, do not block the induction of long-term potentiation at therapeutically relevant concentrations.
    Kapus G; Székely JI; Durand J; Ruiz A; Tarnawa I
    Brain Res Bull; 2000 Aug; 52(6):511-7. PubMed ID: 10974490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-NMDA receptor antagonist GYKI 52466 suppresses cortical afterdischarges in immature rats.
    Kubová H; Világi I; Mikulecká A; Mares P
    Eur J Pharmacol; 1997 Aug; 333(1):17-26. PubMed ID: 9311656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of AMPA-receptors attenuates 4-aminopyridine seizures, decreases the activation of inhibitory neurons but is ineffective against seizure-related astrocytic swelling.
    Weiczner R; Krisztin-Péva B; Mihály A
    Epilepsy Res; 2008 Jan; 78(1):22-32. PubMed ID: 18036781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated application of 4-aminopyridine provoke an increase in entorhinal cortex excitability and rearrange AMPA and kainate receptors.
    Borbély S; Czégé D; Molnár E; Dobó E; Mihály A; Világi I
    Neurotox Res; 2015 May; 27(4):441-52. PubMed ID: 25576253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-N-methyl-D-aspartate receptor antagonism by 3-N-substituted 2,3-benzodiazepines: relationship to anticonvulsant activity.
    Donevan SD; Yamaguchi S; Rogawski MA
    J Pharmacol Exp Ther; 1994 Oct; 271(1):25-9. PubMed ID: 7525924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of the dye Evans Blue and GYKI 52466, a 2,3-benzodiazepine, with (S)- alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors in cultured rat cortical neurons: electrophysiological evidence for at least two different binding sites for non-competitive antagonists.
    Weiser T; Herrmann A; Wienrich M
    Neurosci Lett; 1996 Sep; 216(1):29-32. PubMed ID: 8892384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclothiazide prolongs low [Mg2+]-induced seizure-like events.
    Lasztóczi B; Kardos J
    J Neurophysiol; 2006 Dec; 96(6):3538-44. PubMed ID: 16914619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models.
    Yamaguchi S; Donevan SD; Rogawski MA
    Epilepsy Res; 1993 Jul; 15(3):179-84. PubMed ID: 7693450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of GYKI 52466, a selective non-competitive antagonist of AMPA/kainate receptors, with conventional antiepileptic drugs in amygdala-kindled seizures in rats.
    Borowicz KK; Duda AM; Kleinrok Z; Czuczwar SJ
    Pol J Pharmacol; 2001; 53(2):101-8. PubMed ID: 11787948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of kainate-induced responses by pentobarbitone and GYKI-53784 in rat abducens motoneurons in vivo.
    Ruiz A; Durand J
    Brain Res; 1999 Feb; 818(2):421-30. PubMed ID: 10082828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuroprotective and hypothermic effect of GYKI-52466, a non-competitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-antagonist on histological and behavioural variables in the gerbil global ischemia model.
    Gyertyán I; Gigler G; Simó A
    Brain Res Bull; 1999 Oct; 50(3):179-86. PubMed ID: 10566979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMPA-preferring receptors mediate excitatory synaptic inputs to retinal ganglion cells.
    Lukasiewicz PD; Wilson JA; Lawrence JE
    J Neurophysiol; 1997 Jan; 77(1):57-64. PubMed ID: 9120596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of ionotropic glutamate receptor-mediated processes in the rat hippocampus following repeated, brief seizures.
    Borbély S; Dobó E; Czégé D; Molnár E; Bakos M; Szucs B; Vincze A; Világi I; Mihály A
    Neuroscience; 2009 Mar; 159(1):358-68. PubMed ID: 19154779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of AMPA receptors in trigeminal post-synaptic potentials recorded in rat abducens motoneurons in vivo.
    Ouardouz M; Durand J
    Eur J Neurosci; 1994 Nov; 6(11):1662-8. PubMed ID: 7874305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines.
    Donevan SD; Rogawski MA
    Neuroscience; 1998 Dec; 87(3):615-29. PubMed ID: 9758228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.